Development of tizanidine loaded aspasomes as transdermal delivery system: ex-vivo and in-vivo evaluation

References

• Abdel Azim, A.M., et al., 2014. Transdermal films containing tizanidine: in vitro and in vivo evaluation. Journal of drug delivery science and technology, 24(1), 92–99.
   Web of Science ®Google Scholar
• Abdelbary, G., and El-Gendy, N., 2008. Niosome-encapsulated gentamicin for ophthalmic controlled delivery. AAPS pharmscitech, 9(3), 740–747.
   PubMed Web of Science ®Google Scholar
• Abdelkader, H., Alani, A.W., and Alany, R.G., 2014. Recent advances in non-ionic surfactant vesicles (niosomes): self-assembly, fabrication, characterization, drug delivery applications and limitations. Drug delivery, 21(2), 87–100.
   PubMed Web of Science ®Google Scholar
• Alkilani, A.Z., McCrudden, M.T., and Donnelly, R.F., 2015. Transdermal drug delivery: innovative pharmaceutical developments based on disruption of the barrier properties of the stratum corneum. Pharmaceutics, 7(4), 438–470.
   PubMed Web of Science ®Google Scholar
• Barry, B.W., 2001. Novel mechanisms and devices to enable successful transdermal drug delivery. European journal of pharmaceutical sciences, 14(2), 101–114.
   PubMed Web of Science ®Google Scholar
• Basha, M., et al., 2015. Benzocaine loaded solid lipid nanoparticles: formulation design, in vitro and in vivo evaluation of local anesthetic effect. Current drug delivery, 12(6), 680–692.
   PubMed Web of Science ®Google Scholar
• Basiri, L., Rajabzadeh, G., and Bostan, A., 2017. Physicochemical properties and release behavior of span 60/tween 60 niosomes as vehicle for α-tocopherol delivery. Lwt - Lwt, 84, 471–478.
   Web of Science ®Google Scholar
• Cherukuri, S., et al., 2017. Formulation and evaluation of transdermal drug delivery of topiramate. International journal of pharmaceutical investigation, 7(1), 10–17.
   PubMed Web of Science ®Google Scholar
• Chou, R., Peterson, K., and Helfand, M., 2004. Comparative efficacy and safety of skeletal muscle relaxants for spasticity and musculoskeletal conditions: a systematic review. Journal of pain and symptom management, 28(2), 140–175.
   PubMed Web of Science ®Google Scholar
• Draize, J.H., Woodward, G., and Calvery, H.O., 1944. Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. Journal of pharmacology and experimental therapeutics, 82(3), 377–390.
   Google Scholar
• El-Sayed, M.M., et al., 2017. Flurbiprofen-loaded niosomes-in-gel system improves the ocular bioavailability of flurbiprofen in the aqueous humor. Drug development and industrial pharmacy, 43(6), 902–910.
   PubMed Web of Science ®Google Scholar
• Essa, A.E., 2010. Effect of formulation and processing variables on the particle size of sorbitan monopalmitate niosomes. Asian journal of pharmaceutics, 4(4), 227–233.
   Google Scholar
• Gaur, P.K., et al., 2014. Development of a new nanovesicle formulation as transdermal carrier: formulation, physicochemical characterization, permeation studies and anti-inflammatory activity. Artificial cells, nanomedicine, and biotechnology, 42(5), 323–330.
   PubMed Web of Science ®Google Scholar
• Ghosh, S., et al., 2018. Methotrexate aspasomes against rheumatoid arthritis: optimized hydrogel loaded liposomal formulation with in vivo evaluation in Wistar rats. AAPS Pharmscitech, 19(3), 1320–1336.
   PubMed Web of Science ®Google Scholar
• Gopinath, D., et al., 2004. Ascorbyl palmitate vesicles (Aspasomes): formation, characterization and applications. International journal of pharmaceutics, 271(1–2), 95–113.
   PubMed Web of Science ®Google Scholar
• Gosenca, M., et al., 2013. Lecithin based lamellar liquid crystals as a physiologically acceptable dermal delivery system for ascorbyl palmitate. European journal of pharmaceutical sciences, 50(1), 114–122.
   PubMed Web of Science ®Google Scholar
• Guy, R.H., 2010. Transdermal drug delivery. The handbook of experimental pharmacology, 197(197), 399–410.
   Google Scholar
• Henney, H.R., et al., 2008. Relative bioavailability of tizanidine hydrochloride capsule formulation compared with capsule contents administered in applesauce: a single-dose, open-label, randomized, two-way, crossover study in fasted healthy adult subjects. Clinical therapeutics, 30(12), 2263–2271.
   PubMed Web of Science ®Google Scholar
• Honeywell-Nguyen, P.L., and Bouwstra, J.A., 2005. Vesicles as a tool for transdermal and dermal delivery. Drug discovery today: technologies, 2(1), 67–74.
   PubMedGoogle Scholar
• Hussain, A., et al., 2017. Elastic liposomes as novel carriers: recent advances in drug delivery. International journal of nanomedicine, 12, 5087–5108.
   PubMed Web of Science ®Google Scholar
• ICH. 2005. ICH Q2 (R1) validation of analytical procedures ICH. Geneva: International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use.
   Google Scholar
• Jain, S., et al., 2017. Recent advances in lipid-based vesicles and particulate carriers for topical and transdermal application. Journal of pharmaceutical sciences, 106(2), 423–445.
   PubMed Web of Science ®Google Scholar
• Khalil, R.M., et al., 2017. Enhancement of lomefloxacin HCl ocular efficacy via niosomal encapsulation: in vitro characterization and in vivo evaluation. Journal of liposome research, 27(4), 312–323.
   PubMed Web of Science ®Google Scholar
• Khalil, R.M., et al., 2019. Evaluation of bilosomes as nanocarriers for transdermal delivery of tizanidine hydrochloride: in vitro and ex vivo optimization. Journal of liposome research, 29(2), 171–182.
   PubMed Web of Science ®Google Scholar
• Kristl, J., et al., 2003. Effect of colloidal carriers on ascorbyl palmitate stability. European journal of pharmaceutical sciences, 19(4), 181–189.
   PubMed Web of Science ®Google Scholar
• Kurmi, B.D., et al., 2017. Transdermal drug delivery: opportunities and challenges for controlled delivery of therapeutic agents using nanocarriers. Current drug metabolism, 18(5), 481–495.
   PubMed Web of Science ®Google Scholar
• Lee, H., et al., 2018. Device-assisted transdermal drug delivery. Advanced drug delivery reviews, 127, 35–45.
   PubMed Web of Science ®Google Scholar
• Leuenberger, H., El-Arini, S. K., and Betz, G., 2018. Pharmaceutical powder technology—ICH Q8 and building the pyramid of knowledge. In: R. Liu, ed. Water-insoluble drug formulation. Boca Raton, FL: Taylor & Francis Group, 613–645.
   Google Scholar
• Li, X., et al., 2012. Diclofenac/biodegradable polymer micelles for ocular applications. Nanoscale, 4(15), 4667–4673.
   PubMed Web of Science ®Google Scholar
• Liu, J., et al., 2012. Relative bioavailability and pharmacokinetic comparison of two different enteric formulations of omeprazole. Journal of Zhejiang university science B, 13(5), 348–355.
   PubMed Web of Science ®Google Scholar
• Moawad, F.A., Ali, A.A., and Salem, H.F., 2017. Nanotransfersomes-loaded thermosensitive in situ gel as a rectal delivery system of tizanidine HCl: preparation, in vitro and in vivo performance. Drug delivery, 24(1), 252–260.
   PubMed Web of Science ®Google Scholar
• Moribe, K., et al., 2010. Ascorbyl dipalmitate/PEG-lipid nanoparticles as a novel carrier for hydrophobic drugs. International journal of pharmaceutics, 387(1–2), 236–243.
   PubMed Web of Science ®Google Scholar
• Mutalik, S., et al., 2009. A combined approach of chemical enhancers and sonophoresis for the transdermal delivery of tizanidine hydrochloride. Drug Delivery, 16(2), 82–91.
   PubMed Web of Science ®Google Scholar
• Nanda, S., Saroha, K., and Sharma, B., 2014. Formulation, evaluation and optimization of transdermal gel of ketorolac tromethamine using face centered central composite design. International journal of pharmacy and pharmaceutical sciences, 6(4), 133–139.
   Google Scholar
• Nounou, M.M., et al., 2006. In vitro release of hydrophilic and hydrophobic drugs from liposomal dispersions and gels. Acta pharmaceutica, 56(3), 311–324.
   PubMedGoogle Scholar
• Patel, K.K., Kumar, P., and Thakkar, H.P., 2012. Formulation of niosomal gel for enhanced transdermal lopinavir delivery and its comparative evaluation with ethosomal gel. AAPS pharmscitech, 13(4), 1502–1510.
   PubMed Web of Science ®Google Scholar
• Rajabalaya, R., et al., 2016. Tolterodine tartrate proniosomal gel transdermal delivery for overactive bladder. Pharmaceutics, 8(3), 27–15.
   Web of Science ®Google Scholar
• Shanker, G., et al., 2009. Formulation and evaluation of bioadhesive buccal drug delivery of tizanidine hydrochloride tablets. AAPS pharmscitech, 10(2), 530–539.
   PubMed Web of Science ®Google Scholar
• Someshwar, K., et al., 2011. Formulation and evaluation of effervescent floating tablets of tizanidine hydrochloride. Acta pharmaceutica, 61(2), 217–226.
   PubMed Web of Science ®Google Scholar
• Song, C.K., et al., 2012. A novel vesicular carrier, transethosome, for enhanced skin delivery of voriconazole: characterization and in vitro/in vivo evaluation. Colloids and surfaces B: biointerfaces, 92, 299–304.
   PubMed Web of Science ®Google Scholar
• Špiclin, P., Gašperlin, M., and Kmetec, V., 2001. Stability of ascorbyl palmitate in topical microemulsions. International journal of pharmaceutics, 222(2), 271–279.
   PubMed Web of Science ®Google Scholar
• Szunerits, S., and Boukherroub, R., 2018. Heat: a highly efficient skin enhancer for transdermal drug delivery. Frontiers in bioengineering and biotechnology, 6, 1–15.
   PubMed Web of Science ®Google Scholar
• Taghizadeh, S.M., Moghimi-Ardakani, A., and Mohamadnia, F., 2015. A statistical experimental design approach to evaluate the influence of various penetration enhancers on transdermal drug delivery of buprenorphine. Journal of advanced research, 6(2), 155–162.
   PubMed Web of Science ®Google Scholar
• Teeranachaideekul, V., Muller, R.H., and Junyaprasert, V.B., 2007. Encapsulation of ascorbyl palmitate in nanostructured lipid carriers (NLC): effects of formulation parameters on physicochemical stability. International journal of pharmaceutics, 340(1–2), 198–206.
   PubMed Web of Science ®Google Scholar
• Vyas, S.P., et al., 2005. Non-ionic surfactant based vesicles (niosomes) for non-invasive topical genetic immunization against hepatitis B. International journal of pharmaceutics, 296(1–2), 80–86.
   PubMed Web of Science ®Google Scholar
• Yamane, M.A., Williams, A.C., and Barry, B.W., 1995. Terpene penetration enhancers in propylene glycol/water co-solvent systems: effectiveness and mechanism of action. Journal of pharmacy and pharmacology, 47(12A), 978–989.
   PubMed Web of Science ®Google Scholar
• Yusuf, M., Sharma, V., and Pathak, K., 2014. Nanovesicles for transdermal delivery of felodipine: development, characterization, and pharmacokinetics. International journal of pharmaceutical investigation, 4(3), 119–130.
   PubMedGoogle Scholar
• Zhang, Y., et al., 2017. Ascorbyl palmitate/d-alpha-tocopheryl polyethylene glycol 1000 succinate monoester mixed micelles for prolonged circulation and targeted delivery of compound K for antilung cancer therapy in vitro and in vivo. International journal of nanomedicine, 12, 605–614.
   PubMed Web of Science ®Google Scholar